Dieses Ergebnis aus ScienceDirect kann Gästen nicht angezeigt werden. Login für vollen Zugriff.

Tiragolumab plus atezolizumab and chemotherapy as first-line treatment for patients with unresectable oesophageal squamous cell carcinoma (SKYSCRAPER-08): a randomised, double-blind, placebo-controlled, phase 3 trial

Title:	Tiragolumab plus atezolizumab and chemotherapy as first-line treatment for patients with unresectable oesophageal squamous cell carcinoma (SKYSCRAPER-08): a randomised, double-blind, placebo-controlled, phase 3 trial
Authors:	Hsu, Chih-Hung ^{a, }; Lu, Zhihao ^{b, }; Gao, Shegan ^{c, }; Wang, Junye ^d; Sun, Jong-Mu ^e; Liu, Tianshu ^f; Fan, Qingxia ^g; Cai, Jun ^h; Ge, Feijiao ^h; Li, Sijing ^h; Zhang, Li ⁱ; Cha, Edward ^j; Allen, Simon ^{j, k}; Shen, Lin ^{l, }
Source:	In The Lancet Oncology January 2026 27(1):103-115
Database:	ScienceDirect